Overview:
ProductName | WY-14643 |
Description | PPARalphaagoNIST |
Purity | 98.5%(HPLC);NMR(Conforms);MS(Conforms) |
CASNo. | 50892-23-4 |
MolecularFormula | C14H14ClN3O2S |
MolecularWeight | 323.8 |
Properties
StorageTemperature | -20ºC |
ShippingTemperature | ShippedAmbient |
ProductType | Agonist |
Solubility | SolubleinDMSO(40mg/ml) |
Source | Synthetic |
Appearance | Offwhitepowder |
SMILES | Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)O)Cl |
InChI | InChI=1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h4-6H,7H2,1-2H3,(H,19,20)(H,16,17,18) |
InChIKey | SZRPDCCEHVWOJX-UHFFFAOYSA-N |
SafetyPhrases | Classification:D2BToxicMaterialCausingOtherToxicEffectsModerateskinirritant-Moderaterespiratoryirritant,ModerateeyeirritantHazardstatement(s):H302Harmfulifswallowed.H315Causesskinirritation.H319Causesseriouseyeirritation.H335Maycauserespiratoryirritation.H350Maycausecancer.Precautionarystatement(s):P201Obtainspecialinstructionsbeforeuse.P261Avoidbreathingdust/fume/gas/mist/vapours/spray.P305+P351+P338IFINEYES:Rinsecautiouslywithwaterforseveralminutes.Removecontactlenses,ifpresentandeasytodo.Continuerinsing.P308+P313IFexposedorconcerned:Getmedicaladvice/attention. |
CiteThisProduct | WY-14643(StressMarqBiosciencesInc.,VictoriaBCCANADA,Catalog#SIH-531) |
BIOLOGicalDescription
AlternativeNames | 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioaceticacid,Pirinixicacid,2-[4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl]sulfanylaceticacid,WY-14,643,WY14643,WY14643,Wyeth14,643 |
ResearchAreas | Cancer,CancerCarbohydrateMetabolism,CancerLipidandLipoproteinMetabolism,CancerMetabolism |
PubChemID | 5694 |
ProductImages
ChemicalstructureofWY-14643(SIH-531),aPPARalphaagonist.CAS#:50892-23-4.MolecularFormula:C14H14ClN3O2S.MolecularWeight:323.8g/mol.
ProductCitations(0)
Currentlytherearenocitationsforthisproduct.